LOGIN  |  REGISTER
C4 Therapeutics
Chimerix

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

April 18, 2024 | Last Trade: US$2.15 0.06 2.87
  •  The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin (U.S.), Tokyo, Japan and Tianjin, China
  •  Each facility offers a range of educational opportunities designed to advance patient care using the Accuray CyberKnife® and Radixact® Systems

MADISON, Wis., April 18, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of its commitment to advancing patient care the company has opened a new training center in Genolier, Switzerland, that will serve as the European education hub for radiosurgery and radiotherapy product training, and sharing of best practices and innovative techniques using the latest model Accuray CyberKnife® and Radixact® Radiation Treatment Delivery Systems and Accuray Precision® Treatment Planning System. The Genolier based center is the most recent addition to the Accuray network of advanced training facilities with sites located strategically around the world to make it easier for medical care teams to obtain state-of-the-art clinical education.

Inauguration of the Accuray Training Center in Genolier, Switzerland

The Genolier training facility includes hands-on simulation facilities for the CyberKnife and Radixact Systems to be used for training and demonstrations, and meeting rooms equipped with the most advanced technologies to host seminars, workshops and educational events. Training will be tailored to meet the unique requirements of the various medical professionals involved in the care of patients using radiotherapy and radiosurgery, including neurosurgeons, radiation oncologists, medical physicists, dosimetrists and radiotherapy technologists. The center sits within the Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, whose grand opening will occur later this year.

"People diagnosed with cancer rely on their medical team to recommend and deliver a personalized, precise and safe treatment for their specific condition. While our customers have multiple educational resources available to them, we play an important role and are dedicated to supporting their efforts to gain the knowledge and skills required to provide access to radiotherapy in their community and drive the highest level of patient care. Our partnership with Genolier Innovation Hub will help us to do just that by providing an incredible site to access high-quality hands-on training and learn from renowned faculty," said Suzanne Winter, president and chief executive officer of Accuray.

The CyberKnife and Radixact Systems have complementary clinical applications with the same goal: to empower customers to deliver the most precise and accurate treatments while still minimizing dose to healthy tissue, helping to reduce the risk of side effects that may impact patients' quality of life. The systems include advanced functionality that make it easier and more efficient to administer extremely precise radiation treatments, even to targets that move, providing the medical care team with options for managing the full spectrum of cancer cases, from routine to complex and initial treatment to retreatment, and neurologic disorders.

About Accuray

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
This email address is being protected from spambots. You need JavaScript enabled to view it.

Chimerix

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB